InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,486.43
(
0.16%
)
US TECH 100
19,253.20
(
0.20%
)
Dow Jones
39,115.01
(
-0.03%
)
Brent Oil
85.19
(
0.85%
)
Bitcoin
61,727.09
(
1.50%
)
Post# of 4764
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: None

Thursday, 06/14/2007 12:20:56 PM

Thursday, June 14, 2007 12:20:56 PM

Post# of 4764
New patent application for humanized version of C225.

Why is IMCL patenting a humanized version of C225, when it has a fully human (phage-display-derived antibody) in clinical trials (phase II/III)? If anyone has any insight on this please let me know.

biophud

http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FP...

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up